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Toxoplasma gondii is an obligate intracellular 
protozoan responsible for infections throughout the 
world in a wide range of hosts including humans. 
Primary infection is usually subclinical but in some 
patients cervical lymphadenopathy or ocular disease 
can be present [1]. Infection acquired during preg-
nancy may cause severe damage to the fetus. In im-
munocompromised patients, reactivation of latent 
infection can cause life-threatening encephalitis [1]. T. 
gondii infection can be diagnosed indirectly with se-
rological methods and directly by Polymerase Chain 
Reaction (PCR), hybridisation, isolation, and histol-
ogy. Whereas indirect serological methods are widely 
used in immunocompetent patients, definitive diag-
nosis in immunocompromised people is mostly un-
dertaken by direct detection of the parasite [1]. 
In our laboratory the diagnosis of infection by T. 
gondii is carried out by the detection of specific 
anti-Toxoplasma immunoglobulin (IgM and IgG) and 
to discriminate chronic from reactivated infection IgG 
avidity is also determined with VIDAS instrument 
(bioMerieux, France) [2]; moreover, the diagnosis of 
toxoplasmosis using bioptic tissue samples, blood, 
and urine is done detecting T. gondii DNA by a 
Real-Time PCR Fluorescence Resonance Energy 
Transfer (FRET), targeting T. gondii 529 bp repeated 
region [3]. The extraction of DNA is performed from 
samples by the MagNA Pure LC instrument (Roche 
Diagnostics, Mannheim, Germany), according to the 
manufacturer’s specifications. For FRET PCR, we 
used the LightCycler Fast-StartDNA MasterPLUS 
Hybridization Probes Kit (Roche Diagnostics), as pre-
viously described [3]. 
During the period 2006-2008 a total of 34,603 sera 
were sent to our laboratory for the diagnosis of infec-
tion by T. gondii. Specific IgM were detected in 1,287 
sera (3.7%), while 33,135 sera (95.8%) were negative 
and 181 (0.5%) equivocal. Specific IgG were detected 
in 7,328 sera (21.2%), while 26,951 sera (77.9%) were 
negative and 324 (0.9%) equivocal. Among the 34,603 
samples analyzed, 88 were from ophthalmological 
clinic of our University Hospital, with 43 samples 
(48.9%) positive, and 1 (1.1%) equivocal for IgG, 4 
samples (4.5%) positive and 1 (1.1%) equivocal for 
IgM, 44 samples (50%) negative for IgG and 83 sam-
ples (94.3%) negative for IgM. In two Human Immu-
nodeficiency Virus (HIV) infected patients with IgG 
positive and IgM negative for T. gondii, the use of 
Real-Time FRET PCR was successfully used to diag-
nose T. gondii retinochoroiditis. For both patients se-
rological assays revealed the absence of IgM and the 
presence of IgG anti-Cytomegalovirus. Antibodies 
anti-Toxocara spp. were negative for one patient and 
not done for the other one. In both patients eosino-
philia was not detected. The first patient presented 
with a progressive deterioration of sight and conjunc-
tival hyperaemia associated with pain and at the 
fundus oculi examination, the ophthalmologist found 
out the presence of an active retinochoroiditis. The 
second patient had a deterioration of sight associated 
with the presence of a retinic scar, subjected to a bi-
opsy to define its aetiology. For both patients the de-
tection of T. gondii DNA by FRET PCR performed on a 
small volume of aqueous humor (<100  μl) gave a 
positive result (Figure 1), allowing to confirm the 
clinical suspect of T. gondii retinochoroiditis. In con-
clusion, as already reported in the literature, amplifi-
cation of T. gondii DNA is a useful tool to support or 
confirm the diagnosis of toxoplasmosis in subjects 
with IgG positive for T. gondii  as the cause of the 
retinal lesions in both aqueous humor and vitreous 
fluid in humans, considering that the detection of Int. J. Med. Sci. 2009, 6 
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local specific antibodies may only provide indirect 
evidence of ocular infection [4]. Moreover, it’s im-
portant to highlight that FRET PCR is able to detect 
the presence of T. gondii DNA on a small amount of 
sample as it was in our experience (<100 μl) from 
ocular compartment. 
 
 
Figure 1: Log amplification curve of Real-time PCR FRET for the detection of T. gondii DNA in aqueous humor showing 
positive result. 1 = T. gondii DNA positive control; 2, 3 = patient sample (aqueous humor) tested in duplicate. 
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